Management of Pregnancy-associated Thrombotic Thrombocytopenia Purpura

Overview

Journal AJP Rep

Date 2013 Aug 15

PMID 23943710

Citations 7

Authors

Ashley Fyfe-Brown

Gwen Clarke

Kara Nerenberg

Sujata Chandra

Venu Jain

Affiliations

Soon will be listed here.

Abstract

Thrombotic thrombocytopenia purpura (TTP) is an infrequent but serious disease. Pregnancy is a known risk factor for presentation or relapse of TTP. Difficulties in differentiating TTP from preeclampsia/HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome, and current treatment recommendations are discussed in this case report. A woman with previously treated and stable TTP had a relapse at 36 weeks' gestation. Careful surveillance led to an early diagnosis. Severe disease in the peripartum period was treated successfully with cryosupernatant plasma-based plasmapheresis and platelet transfusion, with good maternal and neonatal outcomes. Cryosupernatant plasma is a viable alternative to fresh frozen plasma for plasmapheresis for TTP and may offer some therapeutic and logistical advantages. Platelet transfusion can be undertaken safely if needed to prevent or treat significant hemorrhage.

Citing Articles

Thrombotic Thrombocytopenic Purpura Masked by Severe Preeclampsia: A Case Report.

Alabdulmohsen D, Alhashim J Cureus. 2024; 16(11):e74851.

PMID: 39737282 PMC: 11684777. DOI: 10.7759/cureus.74851.

An Interesting Case of Refractory Thrombotic Thrombocytopenic Purpura in the First Trimester of a Twin Pregnancy.

Jacob G, Dhaliwal A, Chaudhary V Cureus. 2023; 15(10):e47153.

PMID: 38021667 PMC: 10652162. DOI: 10.7759/cureus.47153.

Hematologic Findings in Pregnancy: A Guide for the Internist.

Patel P, Balanchivadze N Cureus. 2021; 13(5):e15149.

PMID: 34164247 PMC: 8214837. DOI: 10.7759/cureus.15149.

A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.

Aminimoghaddam S, Afrooz N, Nasiri S, Motaghi Nejad O, Mahmoudzadeh F J Med Case Rep. 2021; 15(1):104.

PMID: 33648584 PMC: 7919244. DOI: 10.1186/s13256-020-02577-5.

Thrombotic Thrombocytopenic Purpura: Revisiting a Miss and an Inevitable Consequence.

Gogia P, Gbujie E, Benge E, Bhasin S Cureus. 2020; 12(7):e9283.

PMID: 32699732 PMC: 7372183. DOI: 10.7759/cureus.9283.

References

Martin Jr J, Bailey A, Rehberg J, Owens M, Keiser S, May W . Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Am J Obstet Gynecol. 2008; 199(2):98-104. DOI: 10.1016/j.ajog.2008.03.011. View

Altuntas F, Aydogdu I, Kabukcu S, Kocyigit I, Cikim K, Sari I . Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci. 2007; 36(1):57-67. DOI: 10.1016/j.transci.2006.05.014. View

He Y, Chen Y, Zhao Y, Zhang Y, Yang W . Clinical study on five cases of thrombotic thrombocytopenic purpura complicating pregnancy. Aust N Z J Obstet Gynaecol. 2010; 50(6):519-22. DOI: 10.1111/j.1479-828X.2010.01222.x. View

George J . Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006; 354(18):1927-35. DOI: 10.1056/NEJMcp053024. View

Scully M, Longair I, Flynn M, Berryman J, Machin S . Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang. 2007; 93(2):154-8. DOI: 10.1111/j.1423-0410.2007.00940.x. View

Lattuada A, Rossi E, Calzarossa C, Candolfi R, Mannucci P . Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica. 2003; 88(9):1029-34. View

Rieger M, Mannucci P, Kremer Hovinga J, Herzog A, Gerstenbauer G, Konetschny C . ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood. 2005; 106(4):1262-7. DOI: 10.1182/blood-2004-11-4490. View

Swisher K, Terrell D, Vesely S, Kremer Hovinga J, Lammle B, George J . Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009; 49(5):873-87. DOI: 10.1111/j.1537-2995.2008.02082.x. View

Remuzzi G, Galbusera M, Noris M, Canciani M, Daina E, Bresin E . von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood. 2002; 100(3):778-85. DOI: 10.1182/blood-2001-12-0166. View

10.

Bobbio-Pallavicini E, Gugliotta L, Centurioni R, Porta C, Vianelli N, Billio A . Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica. 1997; 82(4):429-35. View

11.

Harkness D, Byrnes J, Lian E, Williams W, HENSLEY G . Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA. 1981; 246(17):1931-3. View

12.

Scully M, Starke R, Lee R, Mackie I, Machin S, Cohen H . Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagul Fibrinolysis. 2006; 17(6):459-63. DOI: 10.1097/01.mbc.0000240918.65306.20. View

13.

Rock G, Shumak K, Sutton D, Buskard N, Nair R . Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group. Br J Haematol. 1996; 94(2):383-6. DOI: 10.1046/j.1365-2141.1996.d01-1800.x. View

14.

Molvarec A, Rigo Jr J, Boze T, Derzsy Z, Cervenak L, Mako V . Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost. 2009; 101(2):305-11. View

15.

George J . How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010; 116(20):4060-9. DOI: 10.1182/blood-2010-07-271445. View

16.

Raman R, Yang S, Wu H, Cataland S . ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy. Br J Haematol. 2011; 153(2):277-9. DOI: 10.1111/j.1365-2141.2010.08558.x. View

17.

Byrnes J, Moake J, Klug P, Periman P . Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol. 1990; 34(3):169-74. DOI: 10.1002/ajh.2830340303. View

18.

Michael M, Elliott E, Ridley G, Hodson E, Craig J . Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev. 2009; (1):CD003595. PMC: 7154575. DOI: 10.1002/14651858.CD003595.pub2. View

19.

Myers T, Wakem C, Ball E, Tremont S . Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med. 1980; 92(2 Pt 1):149-55. DOI: 10.7326/0003-4819-92-2-149. View

20.

Nguyen T, Stegmayr B, Busund R, Bunchman T, Carcillo J . Plasma therapies in thrombotic syndromes. Int J Artif Organs. 2005; 28(5):459-65. DOI: 10.1177/039139880502800506. View